2. Academic Validation
  3. DOT1L: a new therapeutic target for aggressive breast cancer

DOT1L: a new therapeutic target for aggressive breast cancer

  • Oncotarget. 2015 Oct 13;6(31):30451-2. doi: 10.18632/oncotarget.5860.
Jeong-Yeon Lee 1,  Gu Kong 1
Affiliations

Affiliation

  • 1 Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea.
PMID: 26427043 DOI: 10.18632/oncotarget.5860
Keywords

Chromosome Section; DOT1L; EMT; breast cancer; histone methylation.

Figures